University of Arkansas for Medical Sciences, Myeloma Research and Molecular Pathology Laboratories
Clark & Enersen worked closely with the University of Arkansas for Medical Sciences to design its new Molecular and Myeloma Laboratory spaces. The project involved conceptual planning, cost estimating, and determining the best way to approach construction to ensure the Department of Pathology could remain fully operational throughout the process. Our team also conducted user interviews to assess individual needs and create an optimal layout, as well as to build productive relationships with various stakeholders.
The new Myeloma Laboratory houses the research efforts of world-renowned Professor of Haematology, Dr. Gareth Morgan, who specializes in personalized medicine strategies for myeloma, leukemia, lymphomas, and other blood cancers that result in new therapeutics for these diseases.
The Molecular Laboratory supports the UAMS Pathology Department and, in particular, Fluorescence In Situ Hybridization (FISH) testing. This method is incredibly valuable for detecting cancer-promoting abnormalities in patients and also helps to identify chromosomal abnormalities in leukemias, including Chronic Lymphocytic Leukemia (CLL) cells.
These spaces play a vital role in the UAMS Medical Center’s mission to provide patient-centered, cost-effective care through a health care system enriched by and committed to education and research.
Stats and Results
| Location | Little Rock, Arkansas |
